Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Inventory: 2018-2024

Historic Inventory for Akebia Therapeutics (AKBA) over the last 7 years, with Dec 2024 value amounting to $16.2 million.

  • Akebia Therapeutics' Inventory fell 9.03% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year decrease of 9.03%. This contributed to the annual value of $16.2 million for FY2024, which is 3.52% up from last year.
  • Per Akebia Therapeutics' latest filing, its Inventory stood at $16.2 million for FY2024, which was up 3.52% from $15.7 million recorded in FY2023.
  • Akebia Therapeutics' Inventory's 5-year high stood at $61.0 million during FY2020, with a 5-year trough of $15.7 million in FY2023.
  • In the last 3 years, Akebia Therapeutics' Inventory had a median value of $16.2 million in 2024 and averaged $17.8 million.
  • Per our database at Business Quant, Akebia Therapeutics' Inventory tumbled by 47.56% in 2020 and then climbed by 3.52% in 2024.
  • Over the past 5 years, Akebia Therapeutics' Inventory (Yearly) stood at $61.0 million in 2020, then tumbled by 39.97% to $36.6 million in 2021, then tumbled by 41.12% to $21.6 million in 2022, then decreased by 27.25% to $15.7 million in 2023, then increased by 3.52% to $16.2 million in 2024.